2019 annual financial data
Cumberland Pharmaceuticals 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was 8.89%.
Operating income was -9,288,182 USD and net income was -3,537,759 USD.
Operating cash flow was 3,056,356 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34,388,295 USD
- Operating income
- -9,288,182 USD
- Net income
- -3,537,759 USD
- Operating cash flow
- 3,056,356 USD